 |
市場調查報告書
商品編碼
1342873
全球痛風治療市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測Global Gout Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
||||||
全球痛風治療市場需求預計將從 2022 年的 62.2 億美元增至 2030 年的近 254.4 億美元，2022-2030 年研究期間年複合成長率為 16.94%。
痛風治療的目的是減輕疼痛并促進全面、早期的緩解。痛風被定義為炎症性關節炎的一般形式。主要是由於血液中尿酸含量較高引起的。痛風可以是急性的，也可以是慢性的。它還可能是由紅肉攝入過多、肥胖和過量飲酒引起的。痛風療法可以幫助治療痛風症狀，預防未來發作，並降低腎結石和痛風石等併發症的風險。
市場動態：
痛風治療市場主要是由生活方式的改變和人口老齡化推動的。飲酒量的增加、高嘌呤飲食的攝入、人們肥胖和腎臟疾病的增加以及利尿劑等某些藥物的消費量的增加是推動痛風治療市場成長的因素。此外，專注於痛風治療藥物創新和開發的研發活動不斷成長，為預測期內該市場提供了成長機會。然而，患者意識的缺乏以及 FDA 對新藥核准的嚴格要求可能會限制市場成長。
該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球痛風治療市場的各個細分市場進行了包容性評估。痛風治療行業的成長和趨勢為這項研究提供了整體方法。
區域分析：
本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲痛風治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。痛風治療市場的主要參與者包括阿斯利康、Hikma Pharmaceuticals plc、Horizon Pharma plc.、Iroko Pharmaceuticals LLC、Merck & CO. Inc.、Mylan NV、Novartis AG、Takeda Pharmaceutical Company Limited、Teijin Pharma Limited. 、Teva Pharmaceutical Industries該部分包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
目錄
第一章：前言
- 報告說明
- 客觀的
- 目標受眾
- 獨特的銷售主張 (USP) 和產品
- 研究範圍
- 研究方法論
- 市場研究過程
- 市場研究方法論
第 2 章：執行摘要
- 市場亮點
- 全球市場概況
第 3 章：痛風治療 - 行業分析
- 簡介 - 市場動態
- 市場促進因素
- 市場限制
- 機會
- 行業動態
- 波特五力分析
- 市場吸引力分析
- 按藥物類型分類的市場吸引力分析
- 按配銷通路分類的市場吸引力分析
- 市場吸引力分析：按地區
第 4 章：價值鏈分析
- 價值鏈分析
- 原料分析
- 原料清單
- 原料廠商清單
- 主要原料價格走勢
- 潛在買家名單
- 行銷管道
- 直效行銷
- 間接行銷
- 行銷管道發展趨勢
第 5 章：COVID-19 爆發的影響分析
第 6 章：全球痛風治療市場分析：按藥物類型
- 按藥物類型概述
- 歷史和預測數據
- 按藥物類型分析
- 非類固醇抗發炎藥
- 秋水仙鹼
- 皮質類固醇
- 降尿酸藥物
- 生物製劑
第 7 章：全球痛風治療市場分析：按配銷通路
- 按配銷通路分類的概覽
- 歷史和預測數據
- 按配銷通路分析
- 醫院藥房
- 零售藥店
- 網上藥店
第 8 章：全球痛風治療市場分析：按地理位置
- 區域展望
- 介紹
- 北美銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美按國家/地區銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
- 歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家/地區銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
- 亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太地區其他地區銷售分析
- 拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家/地區銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
- 中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析
第 9 章：痛風治療公司的競爭格局
- 痛風治療市場競爭
- 夥伴關係/協作/協議
- 併購
- 新產品發布
- 其他發展
第 10 章：公司簡介
- 頂級公司市場佔有率分析
- 市場集中度
- AstraZeneca
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Hikma Pharmaceuticals plc
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Horizon Pharma plc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Iroko Pharmaceuticals LLC
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Merck & CO. Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Mylan NV
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Novartis AG
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Takeda Pharmaceutical Company Limited
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Teijin Pharma Limited.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Teva Pharmaceutical Industries Ltd.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內
The global demand for Gout Therapeutics Market is presumed to reach the market size of nearly USD 25.44 BN by 2030 from USD 6.22 BN in 2022 with a CAGR of 16.94% under the study period 2022 - 2030.
Gout therapeutics aim to reduce pain and promote a full, early resolution. Gout is defined as a general form of inflammatory arthritis. It is mainly caused due to higher levels of uric acid in the blood. Gout can be acute and chronic. It can also be caused by high red meat intake, obesity, and excessive alcohol consumption. Gout therapeutics can help treat gout symptoms, prevent future flares, and lower the risk of complications like kidney stones and tophi.
MARKET DYNAMICS:
The gout therapeutics market is mainly driven by changing lifestyles and the ageing population. The adoption of an increase in alcohol consumption, high intake of purine diet, rising obesity and kidney diseases amongst people, and rising consumption of certain medications such as diuretics are the factors boosting the gout therapeutics market growth. Furthermore, growing R&D activities focusing on innovation and development of gout therapeutics agents provide a growth opportunity for this market during the forecast period. However, a lack of patient awareness and strict FDA requirements for drug approval of new drugs may limit the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gout therapeutics. The growth and trends of gout therapeutics industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the gout therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Drug Type
- NSAIDS
- Colchicine
- Corticosteroids
- Urate-Lowering Drugs
- Biologics
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the Gout Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gout therapeutics market include AstraZeneca, Hikma Pharmaceuticals plc, Horizon Pharma plc., Iroko Pharmaceuticals LLC, Merck & CO. Inc., Mylan N.V., Novartis AG, Takeda Pharmaceutical Company Limited, Teijin Pharma Limited., Teva Pharmaceutical Industries Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . GOUT THERAPEUTICS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Type
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL GOUT THERAPEUTICS MARKET ANALYSIS BY DRUG TYPE
- 6.1 Overview by Drug Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Drug Type
- 6.4 NSAIDS Historic and Forecast Sales by Regions
- 6.5 Colchicine Historic and Forecast Sales by Regions
- 6.6 Corticosteroids Historic and Forecast Sales by Regions
- 6.7 Urate-lowering Drugs Historic and Forecast Sales by Regions
- 6.8 Biologics Historic and Forecast Sales by Regions
7 . GLOBAL GOUT THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- 7.1 Overview by Distribution Channel
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Distribution Channel
- 7.4 Hospital Pharmacies Historic and Forecast Sales by Regions
- 7.5 Retail Pharmacies Historic and Forecast Sales by Regions
- 7.6 Online Pharmacies Historic and Forecast Sales by Regions
8 . GLOBAL GOUT THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE GOUT THERAPEUTICS COMPANIES
- 9.1. Gout Therapeutics Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF GOUT THERAPEUTICS INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Market Concentration Rate
- 10.3. AstraZeneca
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. Hikma Pharmaceuticals plc
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Horizon Pharma plc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Iroko Pharmaceuticals LLC
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Merck & CO. Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Mylan N.V.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. Novartis AG
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Takeda Pharmaceutical Company Limited
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. Teijin Pharma Limited.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. Teva Pharmaceutical Industries Ltd.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Drug Type (USD MN)
- NSAIDS Market Sales by Geography (USD MN)
- Colchicine Market Sales by Geography (USD MN)
- Corticosteroids Market Sales by Geography (USD MN)
- Urate-lowering Drugs Market Sales by Geography (USD MN)
- Biologics Market Sales by Geography (USD MN)
- Analysis Market by Distribution Channel (USD MN)
- Hospital Pharmacies Market Sales by Geography (USD MN)
- Retail Pharmacies Market Sales by Geography (USD MN)
- Online Pharmacies Market Sales by Geography (USD MN)
- Global Gout Therapeutics Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Gout Therapeutics Report
- Market Research Process
- Market Research Methodology
- Global Gout Therapeutics Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Drug Type
- Market Attractiveness Analysis by Distribution Channel
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Drug Type (USD MN)
- NSAIDS Market Sales by Geography (USD MN)
- Colchicine Market Sales by Geography (USD MN)
- Corticosteroids Market Sales by Geography (USD MN)
- Urate-lowering Drugs Market Sales by Geography (USD MN)
- Biologics Market Sales by Geography (USD MN)
- Global Market Analysis by Distribution Channel (USD MN)
- Hospital Pharmacies Market Sales by Geography (USD MN)
- Retail Pharmacies Market Sales by Geography (USD MN)
- Online Pharmacies Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Companies Market Share Analysis
